menu
    • menu

    Company profile for A2 Biotherapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. Our approach addresses the central problem of cancer research: tumor-targeted killing. We focus on targets either lost or gained in cancer cells, potentially creating breakthrough therapies to treat most cancers. The company was founded in 2018 by Alexander K...
    A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. Our approach addresses the central problem of cancer research: tumor-targeted killing. We focus on targets either lost or gained in cancer cells, potentially creating breakthrough therapies to treat most cancers. The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and raised a Series A financing of $57 million. We are currently advancing a pipeline of programs towards the clinic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    A2 BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    30301 Agoura Road #210, Agoura Hills, CA, 91301
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.a2bio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/a2-biotherapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    A2 Bio Presents Safety & Efficacy Data From EVEREST-2 Study
    A2 Bio Presents Safety & Efficacy Data From EVEREST-2 Study

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031980313/en/A2-Biotherapeutics-Presents-Initial-Safety-and-Efficacy-Data-from-Ongoing-Phase-12-EVEREST-2-Study-Including-First-Report-of-a-Complete-Response-to-CAR-T-Cell-Therapy-in-a-Patient-with-NSCLC

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    A2 Bio To Unveil EVEREST-2 Study Data At 2025 SITC Meeting
    A2 Bio To Unveil EVEREST-2 Study Data At 2025 SITC Meeting

    03 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251001069413/en/A2-Bio-to-Present-Early-Safety-and-Efficacy-Data-from-EVEREST-2-Study-during-2025-Annual-Meeting-of-the-Society-for-Immunotherapy-of-Cancer

    BUSINESSWIRE
    03 Oct 2025
    Share Share
    A2 Bio Shares Ph1/2 EVEREST-2 Study Data at Lung Cancer Meeting
    A2 Bio Shares Ph1/2 EVEREST-2 Study Data at Lung Cancer Meeting

    08 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250904676127/en/A2-Biotherapeutics-Presents-Data-from-Ongoing-Phase-12-EVEREST-2-Study-During-the-International-Association-for-the-Study-of-Lung-Cancer-2025-World-Conference-on-Lung-Cancer

    BUSINESSWIRE
    08 Sep 2025
    Share Share
    A2 Bio Doses First Patient in DENALI-1 CAR T Study
    A2 Bio Doses First Patient in DENALI-1 CAR T Study

    26 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250624143809/en/A2-Bio-Announces-First-Patient-Dosed-in-DENALI-1-Phase-12-Clinical-Study-of-A2B395-a-Novel-Allogeneic-Precision-CAR-T-Cell-Therapy-for-Patients-with-Solid-Tumors-that-Express-EGFR

    BUSINESSWIRE
    26 Jun 2025
    Share Share
    A2 Biotherapeutics Secures $80M For Tmod™ Cell Therapy Platform
    A2 Biotherapeutics Secures $80M For Tmod™ Cell Therapy Platform

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250108230204/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share
    A2 Bio Highlights Tmod™ CAR T-Cell Progress at SITC 2024
    A2 Bio Highlights Tmod™ CAR T-Cell Progress at SITC 2024

    09 Nov 2024

    // BUSINESS STD

    https://www.businesswire.com/news/home/20241106161507/en

    BUSINESS STD
    09 Nov 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search